BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wonnacott A, Denby L, Coward RJM, Fraser DJ, Bowen T. MicroRNAs and their delivery in diabetic fibrosis. Adv Drug Deliv Rev 2022;182:114045. [PMID: 34767865 DOI: 10.1016/j.addr.2021.114045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Li C, Ma J, Mali N, Zhang L, Wei T, Shi L, Liu F, Wenxing F, Yang J. Relevance of the pyroptosis-related inflammasome drug targets in the Chuanxiong to improve diabetic nephropathy. Mol Med 2022;28:136. [DOI: 10.1186/s10020-022-00567-5] [Reference Citation Analysis]
2 Zheng Q, Reid G, Eccles MR, Stayner C. Non-coding RNAs as potential biomarkers and therapeutic targets in polycystic kidney disease. Front Physiol 2022;13:1006427. [DOI: 10.3389/fphys.2022.1006427] [Reference Citation Analysis]
3 Wang Y, Feng H, Quan J, Huang K, Wang J, Liu X, Jiang H, Wang X. Target-initiated DNA release-directed catalytic hairpin assembly-based ultrasensitive cyclic amplification sensor detection of serum miRNA. Analytica Chimica Acta 2022. [DOI: 10.1016/j.aca.2022.340437] [Reference Citation Analysis]
4 Wang Y, Zhao M, Zhang Y. Integrated Analysis of Single-Cell RNA-seq and Bulk RNA-seq in the Identification of a Novel ceRNA Network and Key Biomarkers in Diabetic Kidney Disease. IJGM 2022;Volume 15:1985-2001. [DOI: 10.2147/ijgm.s351971] [Reference Citation Analysis]